Research institute at MIT
Appears in 2 stories · Last updated Nov 8, 2026
Home institution for senior authors
MIT researchers have found a way to turn a patient's own natural killer (NK) immune cells into cancer-fighting cells without removing them. The technique uses lipid nanoparticles (LNPs) to deliver messenger RNA (mRNA) that instructs the cells to build chimeric antigen receptors (CARs), the targeting proteins used in CAR T therapies.
Updated 3 days ago
As of September 2026: Host laboratory for the injectable liver-cell research
More than 10,000 Americans with chronic liver disease wait for a transplant, and many are too sick for the surgery. MIT engineers have developed an injectable alternative: liver cells bundled with hydrogel microspheres that settle into the body and form working tissue.
Updated Sep 8
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
